CYCLOSPORINE BLOOD-CONCENTRATIONS DETERMINED BY DIFFERENT ASSAY-METHODS IN HEART-TRANSPLANT PATIENTS

被引：0
|
作者：
ZYLBERKATZ, E
GRANIT, L
机构：
来源：
THERAPEUTIC DRUG MONITORING | 1989年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：592 / 597
页数：6
相关论文
共 50 条
  • [21] CYCLOSPORINE (CSA) ASSOCIATED RENAL CYST FORMATION IN HEART-TRANSPLANT PATIENTS
    JAMES, SH
    LIEN, YH
    BUTLERLEWIS, RJ
    HUNT, RK
    COPELAND, JG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 1015 - 1015
  • [22] IMPROVED IMMUNOSUPPRESSION FOR HEART-TRANSPLANT PATIENTS USING INTRAVENOUS DOSES OF CYCLOSPORINE
    MACRIS, MP
    FRAZIER, OH
    VANBUREN, CT
    LAMMERMEIER, DE
    KAHAN, BD
    TRANSPLANTATION, 1989, 47 (02) : 311 - 314
  • [23] NATURE AND EXTENT OF GLOMERULAR INJURY INDUCED BY CYCLOSPORINE IN HEART-TRANSPLANT PATIENTS
    BERTANI, T
    FERRAZZI, P
    SCHIEPPATI, A
    RUGGENENTI, P
    GAMBA, A
    PARENZAN, L
    MECCA, G
    PERICO, N
    IMBERTI, O
    REMUZZI, A
    REMUZZI, G
    KIDNEY INTERNATIONAL, 1991, 40 (02) : 243 - 250
  • [24] RENAL-FUNCTION AND BLOOD-PRESSURE IN HEART-TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE
    ROTTEMBOURG, J
    MATTEI, MF
    CARBOL, A
    GLUCKMAN, JC
    BEAUFILS, H
    GANDJBAKHCH, I
    CABROL, C
    KIDNEY INTERNATIONAL, 1985, 28 (02) : 399 - 399
  • [25] The impact of everolimus versus mycophenolate on blood and lymphocyte cyclosporine exposure in heart-transplant recipients
    Gustafsson, Finn
    Barth, David
    Delgado, Diego H.
    Nsouli, Meerna
    Sheedy, Jill
    Ross, Heather J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (07) : 659 - 665
  • [26] RENAL-FUNCTION AND BLOOD-PRESSURE UNDER CYCLOSPORINE IN HEART-TRANSPLANT RECIPIENTS
    ROTTEMBOURG, J
    MATTEI, MF
    CABROL, A
    GLUCKMAN, JC
    LEGER, P
    BEAUFILS, H
    PAVIE, A
    AUPETIT, B
    GANDJBAKHCH, I
    CABROL, C
    TRANSPLANTATION PROCEEDINGS, 1986, 18 (05) : 1187 - 1189
  • [27] INTERFERENCE WITH STEADY-STATE CYCLOSPORINE LEVELS BY PROBUCOL IN HEART-TRANSPLANT PATIENTS
    CORDER, CN
    SUNDARARAJAN, V
    LIGUORI, C
    COOPER, DKC
    MUCHMORE, J
    ZUHDI, N
    NOVITZKY, D
    BARBI, G
    LARSCHEID, P
    MANION, CV
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) : 204 - 204
  • [28] Cholesterol-lowering therapy with pravastatin in heart-transplant patients taking cyclosporine A
    Merz, M
    Park, JW
    Krell, B
    Siekmeier, R
    Marz, W
    ATHEROSCLEROSIS, 1997, 129 (01) : 28 - 28
  • [29] The impact of everolimus versus mycophenolate on blood and lymphocyte cyclosporine exposure in heart-transplant recipients
    Finn Gustafsson
    David Barth
    Diego H. Delgado
    Meerna Nsouli
    Jill Sheedy
    Heather J. Ross
    European Journal of Clinical Pharmacology, 2009, 65 : 659 - 665
  • [30] NO EFFECT OF CLODRONATE ON CYCLOSPORINE-A BLOOD-LEVELS IN HEART-TRANSPLANT PATIENTS SIMULTANEOUSLY TREATED WITH DILTIAZEM AND AZATHIOPRINE
    BARALDO, M
    FURLANUT, M
    PURICELLI, C
    THERAPEUTIC DRUG MONITORING, 1994, 16 (04) : 435 - 435
12345